KOSDAQElectrical Equipment054180

Medicox

₩2,295 0.00%2026-11-18 close
Market Cap
₩12.7B
Turnover
₩0
Volume
0 shares
Shares out.
5.5M
PER
—
PBR
0.3×
EPS
-₩2,305
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Narrower losses, unresolved listing risk

Medicox cut its operating loss to KRW 244 million in Q3 2026, but a disclaimer audit opinion on FY2025 and its trading halt keep earnings recovery and listing status both in focus.

  1. 1

    On a filed basis, operating loss narrowed every year, from KRW 12.3 billion in 2022 to KRW 5.75 billion in 2025, and the operating margin improved from -56.5% to -20.4%.

  2. 2

    In Q3 2026 operating loss narrowed to KRW 244 million, while net loss attributable to controlling shareholders widened to KRW 6.34 billion, so the operating and bottom-line trends diverged.

  3. 3

    The FY2025 audit report carried a disclaimer of opinion, citing going-concern uncertainty and a limitation on audit scope, and the disclaimer was also cited as a formal delisting trigger.

  4. 4

    The business is split between ship block fabrication and electric motors and generators, and a Q1 2026 company analysis pointed to rising LNG carrier demand and replacement of aging vessels as tailwinds.

  5. 5

    Total equity stood at KRW 47.1 billion at end-2025 against an accumulated deficit of KRW 69.2 billion, and press reports said current liabilities exceeded current assets by about KRW 8.8 billion.

02

Business structure

Medicox was listed on KOSDAQ in 2001 and mainly fabricates ship blocks such as bows, sterns and engine rooms for specialized vessels.

Its two segments are shipbuilding equipment and electric motors and generators, with ship blocks delivered to a major shipbuilder and motors and generators supplied to Hyosung Heavy Industries and a rail-equipment maker. The company holds three consolidated subsidiaries.

Segment-level revenue shares are not part of the filed figures used here and should be checked against the segment information in the annual report.

The business definition also varies by source: a 2025 disclosure report described it as a special ship-block maker, while an April 2026 report described it as engaged in bio and secondary-battery businesses.

The company has also announced it will acquire a 26.38 percent stake in Happy E&C, a construction and smart road-lighting systems company, to push into new businesses. Within the electrical equipment sector, LS ELECTRIC, Hyosung Heavy Industries and HD Hyundai Electric are larger peers, so the scale gap is wide.

Motors and generators depend on domestic power-equipment demand, so the investment plans of buyers largely drive order volumes.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩6.7B-₩900M−13.8%
2025Q4₩7B-₩1.3B−19.3%
2026Q1₩6.3B-₩1B−16.3%
2026Q2₩6.4B-₩1.1B−17.3%
2026Q3₩7.4B-₩200M−3.3%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩21.8B-₩12.3B-₩42.6B−56.5%−67.4%74.6%
2023₩26.9B-₩10.7B-₩34.4B−39.7%−54.4%54.4%
2024₩30.6B-₩10B-₩21.4B−32.8%−40.9%55.2%
2025₩28.2B-₩5.7B-₩11.9B−20.4%−25.3%44.9%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-18

04

Earnings analysis

On a filed basis, revenue rose from KRW 21.8 billion in 2022 to KRW 26.9 billion in 2023 (up 23.2% year on year) and KRW 30.6 billion in 2024 (up 13.9%), then fell to KRW 28.2 billion in 2025 (down 8.0%). Across 2022 to 2025, 2024 was the largest year by revenue and 2022 the smallest.

Operating loss was KRW 12.3 billion in 2022, KRW 10.7 billion in 2023, KRW 10 billion in 2024 and KRW 5.75 billion in 2025, and the operating margin moved from -56.5% to -39.7%, -32.8% and -20.4% over the same years. On a filed basis, the company posted losses for four straight years from 2022 through 2025.

Net loss attributable to controlling shareholders fell from KRW 42.6 billion in 2022 to KRW 11.9 billion in 2025, and net loss including non-controlling interests followed the same path.

Press reports quoted the company attributing the 2025 narrowing to higher revenue from a rise in orders in its main business segments and better operating margins. The debt ratio fell from 74.6% in 2022 to 44.9% in 2025, and total liabilities were KRW 21.1 billion at end-2025.

Operating cash outflow narrowed from KRW 9.16 billion in 2022 to KRW 3.43 billion in 2025.

Quarterly revenue fell from KRW 6.69 billion in Q3 2025 and KRW 6.98 billion in Q4 2025 to KRW 6.33 billion in Q1 2026, then rose to KRW 6.44 billion in Q2 2026 and KRW 7.43 billion in Q3 2026, the second straight quarter of growth.

Operating loss widened to KRW 1.35 billion in Q4 2025 before narrowing to KRW 1.03 billion in Q1 2026, KRW 1.11 billion in Q2 2026 and KRW 244 million in Q3 2026.

In the same third quarter, net loss attributable to controlling shareholders widened to KRW 6.34 billion from KRW 1.07 billion, so the operating and bottom-line trends diverged. The four latest quarters together total KRW 12.4 billion of net loss attributable to controlling shareholders.

Because the FY2025 audit carried a disclaimer of opinion, the improving trend should be read alongside doubts about the reliability of the financial statements.

05

Industry analysis

Demand on the shipbuilding side looks supportive. A Q1 2026 company analysis pointed to higher demand for high value-added vessels such as LNG carriers and replacement demand for aging ships as lifting shipbuilding-equipment orders.

A late-2025 analysis summary projected that domestic output of power equipment such as motors and generators would rise, driven by higher electricity demand, expanding LNG carrier orders at shipbuilders and large government-backed investment.

The same analysis said delayed investment and maintenance demand had lifted profitability in motors and generators. These are sector-level views and do not guarantee that an individual company will convert orders into revenue.

Medicox is small within the electrical equipment sector, and compared with larger peers such as LS ELECTRIC, Hyosung Heavy Industries and HD Hyundai Electric, the gaps in business scale and financial capacity are wide.

The ship-block business relies on orders from shipbuilders, so changes in the mix of vessel types being ordered can affect order flow. The motors and generators business competes with large power-equipment makers, so pricing and delivery capability are central.

Even if sector demand improves, unresolved audit and funding issues could slow how quickly orders turn into revenue and profit. It is useful to separate the sector-wide demand picture from the company-specific reliability issues.

06

Outlook

The core plan the company has stated is raising funds through a rights offering and convertible bond issuance. The auditor judged that there was insufficient objective evidence supporting the feasibility of this plan and cited it as a basis for the disclaimer of opinion.

On the new-business side, the company disclosed an acquisition of a 26.38 percent stake in Happy E&C, a construction and smart road-lighting systems company, and said it aims to improve profitability through expansion into new businesses and efficiency gains in existing ones.

In the existing business, the next checkpoint is whether the order growth flagged in a Q1 2026 company analysis carried into the 15.4 percent quarter-on-quarter revenue rise in Q3 2026.

Whether the narrowing of operating loss to KRW 244 million continues in Q4 and what drove the wider net loss attributable to controlling shareholders will become clearer in the periodic reports.

The 2026 annual report, the next periodic filing, will show how the diverging operating and bottom-line trends are summarized on an annual basis. The outcome of the trading halt and listing-maintenance review matters more than the business outlook at this stage.

The follow-up audit opinion on the 2026 accounts will indicate whether the going-concern uncertainty has been resolved.

07

Valuation

PER
—
PBR
0.3×
ROE
-27.8%
EPS
-₩2,305
BPS
₩7,096
Dividend per share
₩0

Medicox has posted net losses over the latest four quarters, so a price-to-earnings ratio cannot be calculated. The price-to-book ratio sits in a range where the share price is well below net assets, so the gap between book value and market value is wide.

Market capitalization is below total equity on the balance sheet. Still, equity is the amount left after absorbing the accumulated deficit, and the controlling-shareholder share of equity is the same KRW 47.1 billion at end-2025, so the quality of that equity depends on the audit opinion and the outcome of fundraising.

The operating cash outflow narrowed from KRW 9.16 billion in 2022 to KRW 3.43 billion in 2025 but remains negative. Dividend capacity is limited while the company is loss-making. Valuation here is shaped more by the trading halt, the listing review and fundraising outcomes than by the reported earnings figures.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-18

08

Bull factors

Shrinking operating loss

Operating loss narrowed from KRW 12.3 billion in 2022 to KRW 5.75 billion in 2025 and reached KRW 244 million in Q3 2026. The operating margin improved from -56.5% in 2022 to -20.4% in 2025, which confirms a narrowing at the operating level on a filed basis. Quarterly revenue rose for two straight quarters to KRW 7.43 billion in Q3 2026.

Shipbuilding and power-equipment demand

A Q1 2026 company analysis attributed rising shipbuilding-equipment orders to demand for LNG carriers and replacement of aging vessels. The same analysis said delayed investment and maintenance demand had improved profitability in motors and generators.

A late-2025 analysis summary projected that domestic output of motors and generators would rise on electricity demand and government investment.

New-business expansion

The company said it will acquire a 26.38 percent stake in Happy E&C, a construction and smart road-lighting systems company, to enter new businesses. It plans to diversify and improve profitability by making existing operations more efficient.

How much this investment contributes to earnings, and whether the revenue mix shifts, should be checked in the consolidated notes and segment information of the periodic reports.

09

Bear factors

Disclaimer of opinion

The FY2025 audit report carried a disclaimer of opinion, citing going-concern uncertainty and a limitation on audit scope. The auditor said it could not obtain sufficient objective evidence supporting the feasibility of the rights offering and convertible bond plans.

Because the reliability of the financial information cannot be judged, the improving trend in filed results carries a constraint on how far it can be relied on.

Trading halt and embezzlement case

Seven former executives were indicted on charges including embezzlement, breach of trust and violations of the Capital Markets Act, and the reported embezzlement and breach-of-trust amount is KRW 16.35 billion.

The case led to a listing-eligibility review, and according to reports the company was placed under a trading halt and granted an improvement period. That period was reported as running through August 2026.

Wider net loss and thin buffers

Net loss attributable to controlling shareholders widened to KRW 6.34 billion in Q3 2026 from KRW 1.07 billion in the prior quarter. Across the latest four quarters, that line totals KRW 12.4 billion.

Press reports said current liabilities exceeded current assets by about KRW 8.8 billion at end-2025, which leaves limited room to repay short-term debt.

10

Risk factors

Listing continuity

Whether the company can remain listed will be decided at the end of the improvement period, which was reported as running through August 2026. It must still show restored management transparency, a stronger financial structure and a feasible funding plan.

While trading stays halted, the routes for buying and selling shares remain closed, which limits shareholder liquidity.

Funding

The auditor pointed to a lack of objective support for the rights offering and convertible bond plans. If the convertible bonds convert into shares, the ownership stake of existing shareholders could shrink. Without secured funding, the going-concern premise of the financial statements weakens.

Governance and internal controls

Seven former executives have been indicted, and press reports say prosecutors are investigating the outflow of corporate funds. Governance problems weaken outside confidence in the financial improvement plan.

How internal-control improvements are described in the 2026 annual report and the audit opinion needs to be checked.

11

What to watch next

  1. After December 2026 (ad hoc disclosures)

    Whether trading resumes and the outcome of the listing-eligibility review. A decision to maintain the listing is a precondition for putting the funding plan into practice.

  2. Early February 2027 (the FY2025 annual preliminary results were disclosed on February 9, 2026)

    Full-year 2026 operating loss and net loss attributable to controlling shareholders. This shows whether the wider Q3 2026 net loss of KRW 6.34 billion carried into Q4.

  3. Late March 2027 (annual report filing deadline)

    Whether the FY2026 audit opinion moves away from the FY2025 disclaimer, whether the going-concern uncertainty is resolved, and how segment revenue and funding execution are set out in the periodic report.

  4. Q4 2026 to Q1 2027 (ongoing)

    Whether shipbuilding-block and motors-and-generators orders sustain the Q3 2026 revenue rise and whether quarterly revenue grows for a third straight quarter.

12

Overall view

On a filed basis, Medicox's operating loss and net loss attributable to controlling shareholders narrowed every year from 2022 through 2025, and the operating loss reached KRW 244 million in Q3 2026. Quarterly revenue has also grown for two straight quarters since Q1 2026.

However, the net loss attributable to controlling shareholders widened to KRW 6.34 billion in Q3 2026, so it is too early to judge whether operating-level improvement is carrying through to the bottom line.

The FY2025 audit opinion was a disclaimer, and the embezzlement case and trading-halt history leave listing continuity and funding as the priority issues.

Sector demand for ship blocks and power equipment is presented as a supportive backdrop, but unless the company-specific reliability issues are resolved, the pace at which order growth reaches reported earnings may stay limited.

Equity of KRW 47.1 billion against an accumulated deficit of KRW 69.2 billion and current liabilities above current assets point to thin financial buffers. The next checkpoints are the trading-halt and listing review outcomes, full-year 2026 preliminary results, and the 2026 annual report with its audit opinion. This material is provided for information only and does not include a buy or sell view.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. comp.wisereport.co.kr
  2. comp.fnguide.com
  3. news.nate.com
  4. dealsite.co.kr
  5. newsfc.co.kr
  6. digitaltoday.co.kr
  7. news.nate.com
  8. m.news.nate.com
  9. betanews.net
  10. inthenews.co.kr
  11. kr.investing.com
  12. kpanews.co.kr
  13. asiatime.co.kr
  14. seoul.co.kr
  15. healthfocus.co.kr
  16. businessplus.kr
  17. datatooza.com
  18. pointe.co.kr

Report written 2026-11-19 · Data as of 2026-11-18

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis